A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data

Similar Items

• Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
  by: Bin Wu, et al.
  Published: (2021-02-01)
• Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System
  by: Liwei Wang, et al.
  Published: (2017-07-01)
• Proton pump inhibitors and the risk of adverse cardiac events.
  by: David N Juurlink, et al.
  Published: (2013-01-01)
• Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
  by: Zhuo Ma, et al.
  Published: (2021-07-01)
• OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.
  by: Ruwen Böhm, et al.
  Published: (2016-01-01)